This clinical trial is focused on patients who have undergone surgery for a hip fracture. The study aims to find the best way to prevent constipation, a common issue after such surgeries, by using different types of laxatives. Two treatments are being tested: one containing bisacodyl, a chemical that helps stimulate bowel movements, and another combination treatment that includes simeticone, sodium hydrogen carbonate, potassium chloride, sodium chloride, sodium sulfate anhydrous, and macrogol 4000. These substances work together to ease bowel movements and relieve constipation.

The purpose of the study is to determine which treatment is more effective in preventing constipation after hip surgery. Participants will be randomly assigned to receive either the bisacodyl treatment or the combination treatment. Some participants may receive a placebo. The study will monitor the need for additional medication to manage constipation over a period of 72 hours after surgery.

Throughout the study, participants will take the assigned treatment orally, and their progress will be observed to see how well the treatments work in preventing constipation. The study will help doctors understand which laxative is more effective for patients recovering from hip fracture surgery, ultimately aiming to improve patient care and comfort during recovery.